Trials / Completed
CompletedNCT01364779
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.
Detailed description
A cross-sectional of "aspirin resistance in hemodialysis patients" previously done in our institution showed that 23/66 (34.7%) hemodialysis patients were aspirin resistant. In a recent systematic review, renal impairment was associated with aspirin resistance . This association was seen in only two out of the twenty studies used in this meta-analysis . Both these studies are from the same center with a predominant Asian population. In this study we will try to evaluate the prevalence of aspirin resistance in CKD patient without being limited to a specific ethnicity.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-06-02
- Last updated
- 2013-05-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01364779. Inclusion in this directory is not an endorsement.